公开(公告)号：US20230293616A1

公开(公告)日：2023-09-21

申请号：US17914407

申请日：2021-03-25

申请人： BEIJING UNIVERSITY OF CHINESE MEDICINE THIRD AFFILIATED HOSPITAL

发明人： Chengxiang WANG ,  Hongsheng CUI ,  Weiheng CHEN ,  Huiyong YU ,  Jianjun WU

IPC分类号： A61K36/344 ,  A61K36/284 ,  A61K36/076 ,  A61K36/8968 ,  A61K36/79 ,  A61K36/73 ,  A61K36/535 ,  A61K36/605 ,  A61K36/346 ,  A61K36/736 ,  A61K36/484

CPC分类号： A61K36/344 ,  A61K36/284 ,  A61K36/076 ,  A61K36/8968 ,  A61K36/79 ,  A61K36/73 ,  A61K36/535 ,  A61K36/605 ,  A61K36/346 ,  A61K36/736 ,  A61K36/484 ,  A61K2236/15 ,  A61K2236/39

摘要： A traditional Chinese medicine composition for recovery phase of exogenous fever and a preparation method therefor. The traditional Chinese medicine composition comprises the following raw materials: radix codonopsis, rhizoma atractylodis macrocephalae, poria cocos, radix ophiopogonis, schisandra chinensis, hairyvein agrimony, perilla seeds, cortex moriradicis, folium eriobotryae, radix platycodi, apricot kernels, and radix glycyrrhizae. According to the monarch, minister, assistant and guide theory of traditional Chinese medicines, the radix codonopsis is used as a monarch drug; fried rhizoma atractylodis macrocephalae, the poria cocos, the radix ophiopogonis, the schisandra chinensis, and the hairyvein agrimony are used as minister drugs; the perilla seeds, the cortex moriradicis, and the folium eriobotryae are used as assistant drugs; and the radix platycodi, the apricot kernels, and the radix glycyrrhizae are used as guide drugs. Also disclosed is use of the traditional Chinese medicine composition for rehabilitation treatment of novel coronavirus pneumonia and other exogenous fever in the recovery phase.

公开(公告)号：US11730749B2

公开(公告)日：2023-08-22

申请号：US15973501

申请日：2018-05-07

申请人： Plexus Worldwide, LLC.

发明人： Stephen Roman ,  Tianan Jiang ,  Marco Rebaza

IPC分类号： A61K31/702 ,  A61K36/74 ,  A61K36/605 ,  A61K36/38 ,  A61K31/385 ,  A61K31/216

CPC分类号： A61K31/702 ,  A61K31/216 ,  A61K31/385 ,  A61K36/38 ,  A61K36/605 ,  A61K36/74 ,  A61K36/74 ,  A61K2300/00

摘要： Various embodiments of a gut microbiome modulating composition comprises a blend of a polyphenol and an oligosaccharide. Various embodiments of the polyphenol may comprise at least approximately 5% by weight chlorogenic acid. Various embodiments of the oligosaccharides may be standardized to a degree of polymerization of at least three to reduce digestibility. Administration of an effective amount of the gut microbiome modulating composition to a person or animal may stimulate the growth of at least one of Akkermansia muciniphila, Lactobacillus, and Bifidobacterium bacteria in the colon, which may reduce permeability of the colon, increases short chain fatty acid production in the colon, and/or modulate causes immunomodulation of human colon cells. The gut microbiome modulating composition may provide protective effects against obesity-related chronic diseases.

公开(公告)号：US20230201295A1

公开(公告)日：2023-06-29

申请号：US18084009

申请日：2022-12-19

申请人： Unigen, Inc.

发明人： Qi Jia ,  Ping Jiao ,  Mesfin Yimam ,  Teresa Horm

IPC分类号： A61K36/605 ,  A61K31/7034 ,  A61K36/48 ,  A61K31/352 ,  A61K31/353

CPC分类号： A61K36/605 ,  A61K31/7034 ,  A61K36/48 ,  A61K31/352 ,  A61K31/353 ,  A61K2300/00

摘要： Compositions and methods for bone health, cartilage health or both, are disclosed that include preparing and utilizing a mixture of at least one Morus extract enriched for one or more prenylated flavonoids, at least one Scutellaria extract enriched for one or more free-B-ring flavonoids, and at least one Acacia extract enriched for one or more flavans.

公开(公告)号：US20210330730A1

公开(公告)日：2021-10-28

申请号：US17120207

申请日：2020-12-13

申请人： Jinchang Ai

发明人： Jinchang Ai

IPC分类号： A61K36/73 ,  A61K36/899 ,  A61K36/11 ,  A61K36/258 ,  A61K36/53 ,  A61K36/605 ,  A61K36/82 ,  A61K36/185 ,  A61K36/288

摘要： The application discloses a traditional Chinese medicine composition for treating of type 2 diabetes, comprising the following raw materials: wild Descolor Cinquefoil Herb, wild Rhizoma imperatae, wild Root and Rhizome of Japanese Climbing Fern, Ginseng leaf (over 7 years), wild Rough Melic, wild Vitex negundo L., Morus alba L., green tea, wild auricularia, corn silk, dandelion root. The traditional Chinese medicine composition of the application is suitable for patients with type 2 diabetes and complications of type 2 diabetes, which has no adverse reactions and stable curative effect.

公开(公告)号：US20210283158A1

公开(公告)日：2021-09-16

申请号：US16477052

申请日：2018-01-17

申请人： SAFENAT S.R.L.

发明人： Francesco Paolo BONINA

IPC分类号： A61K31/7048 ,  A61K31/7034 ,  A61K36/899 ,  A61K36/752 ,  A61K36/605 ,  A61K36/73 ,  A61K36/63 ,  A61K36/80 ,  A61P27/02

摘要： The present invention relates to nutraceutical or pharmaceutical compositions based on a combination of cyanidin-3-O-glucoside and verbascoside, or extracts of plant origin enriched in the two active ingredients, with a protective action on eyesight.

公开(公告)号：US20210227866A1

公开(公告)日：2021-07-29

申请号：US17011462

申请日：2020-09-03

申请人： Melaleuca, Inc.

发明人： Jeremy Ivie

IPC分类号： A23L33/105 ,  A61K36/00 ,  A23L33/16 ,  A23L2/39 ,  A23L2/52 ,  A61K33/24 ,  A61K36/258 ,  A61K36/39 ,  A61K36/54 ,  A61K36/605 ,  A61K36/82 ,  A23L33/10 ,  A23L33/19 ,  A23L33/115 ,  A23L33/125 ,  A23L33/185 ,  A23L2/56 ,  A23L2/66

摘要： This document provides dietary supplement compositions as well as methods for using dietary supplement compositions to control glucose levels. For example, a dietary supplement composition including chromium (e.g., Chromium Oligofructose Complex), a sweet potato extract, and one or more of a mulberry extract, a green tea extract, a cinnamon extract, or a ginseng extract (e.g., Korean Red Ginseng extract) are provided.

公开(公告)号：US10757961B2

公开(公告)日：2020-09-01

申请号：US16231200

申请日：2018-12-21

申请人： WORLD PHARMACEUTICAL TECHNOLOGY, LLC.

发明人： Yong Wu ,  Wei Cao ,  Jieqing Li ,  Huabing Yang ,  Ke Wu ,  Shiliu Tian

IPC分类号： A61K31/375 ,  A23L33/105 ,  A23L33/16 ,  A61K36/481 ,  A61K36/73 ,  A61K36/605 ,  A61K36/63 ,  A61K36/42 ,  A61K31/4188 ,  A61K9/00 ,  A61P3/10 ,  A23L33/15

摘要： A formulation for a dietary supplement includes standardized extracts of Astragalus root, phlorizin, root bark of white mulberry, olive leaf, and bitter melon. The formulation may further include chromium, 2-deoxy-D-glucose, biotin, vitamin D and vitamin C. A method of controlling postprandial blood glucose includes administering the formulation for the dietary supplement to a patient.

公开(公告)号：US20200206292A1

公开(公告)日：2020-07-02

申请号：US16812899

申请日：2020-03-09

申请人： Unigen, Inc.

发明人： Qi Jia ,  Ping Jiao ,  Mesfin Yimam ,  Teresa Horm

IPC分类号： A61K36/605 ,  A61K31/352 ,  A61K36/48 ,  A61K31/7034 ,  A61K31/353

摘要： Compositions and methods for bone health, cartilage health or both, are disclosed that include preparing and utilizing a mixture of at least one Morus extract enriched for one or more prenylated flavonoids, at least one Scutellaria extract enriched for one or more free-B-ring flavonoids, and at least one Acacia extract enriched for one or more flavans.

公开(公告)号：US10583161B2

公开(公告)日：2020-03-10

申请号：US15808580

申请日：2017-11-09

申请人： Unigen, Inc.

发明人： Qi Jia ,  Ping Jiao ,  Mesfin Yimam ,  Teresa Horm

IPC分类号： A61K36/00 ,  A61K36/605 ,  A61K31/7034 ,  A61K36/48 ,  A61K31/352

摘要： Compositions and methods for bone health, cartilage health or both, are disclosed that include preparing and utilizing a mixture of at least one Morus extract enriched for one or more prenylated flavonoids, at least one Scutellaria extract enriched for one or more free-B-ring flavonoids, and at least one Acacia extract enriched for one or more flavans.

公开(公告)号：US20190070240A1

公开(公告)日：2019-03-07

申请号：US16184286

申请日：2018-11-08

申请人： Shaoke WANG ,  Theresa Y Y TSE ,  Zhao ZHANG

发明人： Shaoke WANG ,  Theresa Y Y TSE ,  Zhao ZHANG ,  Ping DOU ,  Jingrui XU ,  Hongwei TIAN ,  Wanyu ZHANG

IPC分类号： A61K36/424 ,  A61K36/46 ,  A61K36/605 ,  A61K36/68 ,  A61K36/899 ,  A61K36/488 ,  A61K36/185 ,  A61K36/739 ,  A61P19/02

摘要： A gynostemma pentaphyllum-containing health care pharmaceutical composition for preventing hyperlipidemia, hypertension, hyperglycemia and gout is prepared by mixing raw materials of gynostemma pentaphyllum, folium eucommiae, folium mori, semen plantaginis, herba lophatheri, pueraria mirifica powder, pelargonium graveolens and sanguisorba minor, and the raw materials are in percentage by mass: 40-70% of gynostemma pentaphyllum, 5-20% of folium eucommiae, 5-20% of folium mori, 5-10% of semen plantaginis, 2-10% of herba lophatheri, 2-10% of pueraria mirifica powder, 2-8% of pelargonium graveolens and 2-8% of sanguisorba minor. The gynostemma pentaphyllum is prepared by mixing diploid gynostemma pentaphyllum leaves and tetraploid gynostemma pentaphyllum leaves according to a ratio. The pharmaceutical composition is mainly aimed at people who suffer from hyperlipidemia, hypertension, hyperglycemia and hyperuricemia, and used for preventing and treating the “four hypers